The hypothesis that alterations in tau mRNA level drive pathology is supported by extensive data, including the observation that duplication of genomic regions including MAPT, which increases tau mRNA levels in a dose dependent fashion, is sufficient to cause tauopathy [61]. Here, MAPT is linked to tauopathy.